David Bates

4.8k total citations · 1 hit paper
35 papers, 3.5k citations indexed

About

David Bates is a scholar working on Pathology and Forensic Medicine, Neurology and Molecular Biology. According to data from OpenAlex, David Bates has authored 35 papers receiving a total of 3.5k indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Pathology and Forensic Medicine, 8 papers in Neurology and 7 papers in Molecular Biology. Recurrent topics in David Bates's work include Multiple Sclerosis Research Studies (9 papers), Neurological diseases and metabolism (4 papers) and Acute Ischemic Stroke Management (4 papers). David Bates is often cited by papers focused on Multiple Sclerosis Research Studies (9 papers), Neurological diseases and metabolism (4 papers) and Acute Ischemic Stroke Management (4 papers). David Bates collaborates with scholars based in United Kingdom, United States and France. David Bates's co-authors include J.M. French, Helen Rodgers, J. Grimley Evans, F. K. E. Tunbridge, F. CLARK, David R. Appleton, Mark Vanderpump, David Hasan, E. T. Young and N.E.F. Cartlidge and has published in prestigious journals such as The Lancet, Nature Genetics and Brain.

In The Last Decade

David Bates

35 papers receiving 3.3k citations

Hit Papers

The incidence of thyroid ... 1995 2026 2005 2015 1995 500 1000 1.5k

Author Peers

Peers are selected by citation overlap in the author's most active subfields. citations · hero ref

Author Last Decade Papers Cites
David Bates 1.6k 714 578 547 336 35 3.5k
Martin Andrassy 467 0.3× 206 0.3× 831 1.4× 320 0.6× 78 0.2× 49 3.3k
Emilia Sbardella 1.0k 0.7× 162 0.2× 440 0.8× 912 1.7× 447 1.3× 101 3.0k
Tsutomu Araki 349 0.2× 254 0.4× 1.1k 1.9× 342 0.6× 171 0.5× 139 4.7k
Regien G. Schoemaker 286 0.2× 456 0.6× 1.0k 1.8× 945 1.7× 94 0.3× 108 4.8k
James E. Faber 325 0.2× 685 1.0× 2.0k 3.5× 263 0.5× 609 1.8× 146 5.9k
Marios K. Georgakis 408 0.3× 273 0.4× 435 0.8× 146 0.3× 265 0.8× 100 3.2k
Rita Peila 515 0.3× 573 0.8× 526 0.9× 54 0.1× 222 0.7× 55 3.3k
Masayuki Fujioka 377 0.2× 544 0.8× 392 0.7× 89 0.2× 687 2.0× 75 2.5k
Roald Omdal 247 0.2× 149 0.2× 463 0.8× 590 1.1× 721 2.1× 133 4.1k
James W. Russell 702 0.5× 311 0.4× 658 1.1× 111 0.2× 830 2.5× 76 3.4k

Countries citing papers authored by David Bates

Since Specialization
Citations

This map shows the geographic impact of David Bates's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Bates with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Bates more than expected).

Fields of papers citing papers by David Bates

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by David Bates. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Bates. The network helps show where David Bates may publish in the future.

Co-authorship network of co-authors of David Bates

This figure shows the co-authorship network connecting the top 25 collaborators of David Bates. A scholar is included among the top collaborators of David Bates based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with David Bates. David Bates is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Fredrikson, S., Euan McLeod, Nathaniel Henry, et al.. (2013). A cost-effectiveness analysis of subcutaneous interferon beta-1a 44mcg 3-times a week vs no treatment for patients with clinically isolated syndrome in Sweden. Journal of Medical Economics. 16(6). 756–762. 5 indexed citations
2.
Burks, J. S., Michael B. Chancellor, David Bates, et al.. (2013). Development and Validation of the Actionable Bladder Symptom Screening Tool for Multiple Sclerosis Patients. International Journal of MS Care. 15(4). 182–192. 38 indexed citations
3.
Bates, David, J. S. Burks, Denise Globe, et al.. (2013). Development of a short form and scoring algorithm from the validated actionable bladder symptom screening tool. BMC Neurology. 13(1). 78–78. 21 indexed citations
4.
Bates, David & E Bartholomé. (2011). Treatment effect of natalizumab on relapse outcomes in multiple sclerosis patients despite ongoing MRI activity. Journal of Neurology Neurosurgery & Psychiatry. 83(1). 55–60. 13 indexed citations
5.
White, Kathryn, Christine E. Thomson, Julia M. Edgar, et al.. (2006). Increased axonal mitochondrial activity as an adaptation to myelin deficiency in the Shiverer mouse. Journal of Neuroscience Research. 83(8). 1533–1539. 83 indexed citations
6.
Bates, David. (2006). Can somatosensory evoked potentials and neuron-specific enolase reliably predict outcome in postanoxic coma?. Nature Clinical Practice Neurology. 2(9). 472–473. 1 indexed citations
7.
Bates, David, Klaus V. Toyka, Jerry S. Wolinsky, & Douglas L. Arnold. (2005). Disease Management in Multiple Sclerosis. European Neurology. 53(4). 203–205. 1 indexed citations
8.
Bates, David, et al.. (2004). Mitochondrial dysfunction plays a key role in progressive axonal loss in Multiple Sclerosis. Medical Hypotheses. 64(4). 669–677. 67 indexed citations
9.
Crompton, Douglas E., Patrick F. Chinnery, David Bates, et al.. (2004). Spectrum of movement disorders in neuroferritinopathy. Movement Disorders. 20(1). 95–99. 36 indexed citations
10.
Chinnery, Patrick F., Timothy J. Walls, Michael G. Hanna, David Bates, & P. Fawcett. (2002). Normokalemic periodic paralysis revisited: Does it exist?. Annals of Neurology. 52(2). 251–252. 37 indexed citations
11.
Crompton, Douglas E., Patrick F. Chinnery, Andrew R.J. Curtis, et al.. (2002). Neuroferritinopathy: A Window on the Role of Iron in Neurodegeneration. Blood Cells Molecules and Diseases. 29(3). 522–531. 55 indexed citations
12.
Curtis, Andrew R.J., Christopher M. Morris, Laurence A. Bindoff, et al.. (2001). Mutation in the gene encoding ferritin light polypeptide causes dominant adult-onset basal ganglia disease. Nature Genetics. 28(4). 350–354. 386 indexed citations
13.
Bates, David. (1997). Persistent vegetative state and brain stem death. Current Opinion in Neurology. 10(6). 502–506. 3 indexed citations
14.
Vanderpump, Mark, J.M. French, David R. Appleton, et al.. (1995). The incidence of thyroid disorders in the community: a twenty‐year follow‐up of the Whickham Survey. Clinical Endocrinology. 43(1). 55–68. 1706 indexed citations breakdown →
15.
Heald, Andrew, David Bates, N.E.F. Cartlidge, J.M. French, & S. Miller. (1993). Longitudinal study of central motor conduction time following stroke: 1. Natural history of central motor conduction. Brain. 116(6). 1355–1370. 152 indexed citations
16.
Heald, Andrew, David Bates, N.E.F. Cartlidge, J.M. French, & S. Miller. (1993). Longitudinal study of central motor conduction time following stroke: 2. Central motor conduction measured within 72 h after stroke as a predictor of functional outcome at 12 months. Brain. 116(6). 1371–1385. 168 indexed citations
17.
Rodgers, Helen, et al.. (1992). Use of the myometer in assessing stroke patients—a cautionary tale. Disability and Rehabilitation. 14(2). 110–111. 2 indexed citations
18.
FRENCH, JOYCE M., et al.. (1992). Effect of the risk factors for stroke on survival. Neurological Research. 14(2). 94–96. 6 indexed citations
19.
FRENCH, JOYCE M., et al.. (1990). Historical Risk Factors for Stroke: A Case Control Study. Age and Ageing. 19(5). 280–287. 38 indexed citations
20.
Papiha, S.S., J. Boddy, D. F. Roberts, & David Bates. (1989). PHA-induced interferon in multiple sclerosis: association between gamma interferon and clinical and genetical variables. Acta Neurologica Scandinavica. 80(2). 145–150. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026